ImageneBio (IMA) Current Assets (2020 - 2025)

ImageneBio has disclosed Current Assets across 6 years of filings, most recently posting $140.3 million for Q4 2025.

• In Q4 2025, Current Assets rose 1025.18% year-over-year to $140.3 million; the TTM figure through Dec 2025 stood at $140.3 million (up 1025.18% YoY), while the FY2025 annual figure was $140.3 million, up 1025.18% from the prior year.
• Current Assets came in at $140.3 million for Q4 2025 at ImageneBio, down from $147.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $283.2 million in Q1 2021 to a low of $12.5 million in Q4 2024.
• Average Current Assets over 5 years is $172.1 million, with a median of $160.9 million recorded in 2023.
• Year-over-year, Current Assets slumped 93.02% in 2024 and surged 1025.18% in 2025.
• Over 5 years, Current Assets stood at $236.5 million in 2021, then tumbled by 32.35% to $160.0 million in 2022, then increased by 11.66% to $178.7 million in 2023, then tumbled by 93.02% to $12.5 million in 2024, then surged by 1025.18% to $140.3 million in 2025.
• Per Business Quant data, the three most recent Current Assets figures were $140.3 million in Q4 2025, $147.5 million in Q3 2025, and $99.0 million in Q2 2025.